SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including from sellers, advertising, and subscription services through internationally-focused online stores. The AWS segment is composed of global sales of compute, storage, database, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is trending following a strong earnings report, particularly driven by AWS revenue growth that exceeded expectations. The community is discussing the potential for the stock to reach new highs, with some highlighting the company's expansion and AI initiatives as catalysts for future growth. Despite some concerns about workforce reductions, the overall sentiment is bullish, as investors see AMZN as a key player in the tech sector poised for further gains.

UP AND TO THE RIGHT

UPRIGHT CRYPTO ($UPRIGHT) is gaining traction as community members highlight its clean technical structure and potential breakout. The conversation revolves around its solid accumulation range, consistent higher lows, and overall constructive chart patterns. Many believe it is undervalued and showing early signs of strength, with some suggesting smart money is quietly accumulating.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is trending amid news of partnerships with NVIDIA and Uber to develop Level 4 autonomous EVs, sparking community discussion about the potential for re-rating the stock. While some investors express optimism about Lucid becoming a mobility tech partner, others remain concerned about dilution and profitability, especially given the competitive landscape of the EV sector.

NLS Pharmaceutics Ltd. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the treatment of neurobehavioral and neurocognitive disorders. Its product portfolio includes Quilience, a treatment for excessive daytime sleepiness and cataplexy associated with narcolepsy; and Nolazol, a treatment for attention deficit hyperactivity disorder. The company was founded by Ronald Hafner, Eric Konofal, and Alexander Zwyer on June 10, 2015 and is headquartered in Zurich, Switzerland.

NLS Pharmaceutics Ltd

NLS Pharmaceutics is trending as the merger with Kadimastem has been completed, leading to a reverse stock split and ticker change to NCEL. The community is closely watching the opening price and potential for a short squeeze given the new company's market cap and float. Discussions revolve around the combined company's valuation and the mechanics of the share conversion.

This is a legacy token commemorating the pseudonym Satoshi Nakamoto.

Satoshi Nakamoto

$SATOSHI is trending as community members rally around its significance as 'the Bitcoin of memes' and the tokenization of Satoshi Nakamoto's legacy. Discussions highlight upcoming events and spaces, with many expressing conviction in its long-term potential and its role as a cultural movement within the crypto space. The limited supply and strong community are also key talking points.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Strategy is trending due to its Q3 earnings report, sparking discussions about the company's profitability and future prospects tied to Bitcoin's performance. The community is focused on whether Strategy will reach certain price targets and if it will be included in the S&P 500 index. Some traders are wary of MSTR's correlation with Bitcoin and leveraged position.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending amid discussions of a potential bidding war with Novo Nordisk for Metsera, an obesity drug developer, with community members debating the implications of the acquisition and whether Pfizer should pursue alternative targets like Viking Therapeutics. Some investors express frustration with the stock's performance and question the company's direction, while others highlight its high dividend yield and potential for a turnaround. Broader conversations include the competitive landscape of the obesity drug market and potential merger/acquisition scenarios within the pharmaceutical sector.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple's earnings have sparked intense debate, with discussions focusing on the company's revenue beat and strong guidance, particularly for iPhone sales during the holiday quarter. While some investors are optimistic about the future, others express concerns about China revenue and valuation, creating a mixed sentiment within the trading community. The stock's after-hours surge suggests anticipation for continued growth, while skepticism lingers regarding the sustainability of the gains.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending as developers submit projects to its ongoing hackathon, spurring bullish sentiment. The community highlights its undervalued potential and clean technical structure, while also pointing to meme coin opportunities within the Solana ecosystem. Some are also excited about staking opportunities and the potential for Solana ETFs.

Sigma bnb USD

BNBUSD is trending as it experiences a notable bounce from the "Blue Box" support zone, leading to discussions about bullish momentum and potential upside. The community is analyzing whether this signals a larger move, with some traders securing gains and adjusting positions. Despite regulatory pressures, the focus remains on technical analysis and ecosystem resilience.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$JAZZ Jazz Pharmaceuticals and the Spanish Biotechnology company Pharmamar S.A are about to announce a merge of both companies.
Since October 2020, corporate leaders have been studying and getting agreements regarding their respective values and future prospects. 
Jazz Pharmaceuticals has a capitalization of 8.500 million dollars and Pharmamar has a valuation of 3.560 million dollars. The merge will include shares and an economic compensation for Pharmamar stakeholders.
Both companies must call an Extraordinary General Meeting for their stakeholders to approve the merge and explain to them their agreements and the new managers positions.

John Smith

Felipe

Felipe marta

Juan Can

$JAZZ hi alfred .. you can put the link of that news, thanks

StockTwits for iOS

StockTwits Web

Jazz Pharmaceuticals plc

 Jazz Pharmaceuticals and the Spanish Biotechnology company Pharmamar S.A are about to announce a merge of both companies.
Since October 2020, corporate leaders have been studying and getting agreements regarding their respective values and future prospects. 
Jazz Pharmaceuticals has a capitalization of 8.500 million dollars and Pharmamar has a valuation of 3.560 million dollars. The merge will include shares and an economic compensation for Pharmamar stakeholders.
Both companies must call an Extraordinary General Meeting for their stakeholders to approve the merge and explain to them their agreements and the new managers positions.

alfred

@alfredstevens Hello ... I am still waiting for your answer about this news, can you provide a link? ..

Daniel Garrido

 Hello ... I am still waiting for your answer about this news, can you provide a link? ..

@ARIZONA2000 he investment bank that leads the merger.

 he investment bank that leads the merger.

@alfredstevens Thank you .. and does that bank have a name? ... Can you provide more verifiable information, some of the information in your first message is not correct, I don&#39;t know if you know the companies .. Are you an investor in any of them?

 Thank you .. and does that bank have a name? ... Can you provide more verifiable information, some of the information in your first message is not correct, I don't know if you know the companies .. Are you an investor in any of them?